Blood Pressure Goals for Patients with History of Hemorrhagic Stroke
For patients with a history of hemorrhagic stroke, the recommended blood pressure target is <130/80 mmHg, with a systolic target of 140-160 mmHg in the acute phase (within 6 hours of symptom onset) to prevent hematoma expansion and improve functional outcomes. 1, 2
Acute Phase Management (First 72 Hours)
Immediate BP management (within 6 hours of hemorrhage onset):
Medication choices for acute BP control:
Post-Acute Phase Management (After 72 Hours)
For stable patients who remain hypertensive (≥140/90 mmHg) ≥3 days after hemorrhage:
First-line medication options for long-term management:
- RAS blockers (ACE inhibitors or ARBs)
- Calcium channel blockers (CCBs)
- Thiazide diuretics 1
Special Considerations
Risk stratification:
Monitoring recommendations:
Evidence Quality and Considerations
The recommendations are primarily based on recent guidelines from the European Society of Cardiology (2024) 1 and American Heart Association/American College of Cardiology (2018) 1, which provide consistent guidance on BP targets for hemorrhagic stroke patients. The evidence suggests that immediate BP lowering to a systolic target of 140-160 mmHg in the acute phase reduces the risk of hematoma expansion, while long-term management with a target of <130/80 mmHg reduces the risk of recurrent stroke.
The European Society of Cardiology specifically warns against excessive acute drops in systolic BP (>70 mmHg), which may be associated with acute renal injury and early neurological deterioration 1. For long-term management, the International Society of Hypertension recommends RAS blockers, CCBs, and diuretics as first-line drugs 1.
Recent research supports more aggressive BP targets (<120/80 mmHg) for patients at high risk of recurrent hemorrhagic stroke, highlighting the need to balance the risk of ischemic and hemorrhagic events 3.